Only 18% of colorectal cancer patients in the last decade with Kirsten rat sarcoma viral oncogene homolog (KRAS) wild-type tumors received anti-epidermal growth factor receptor (EGFR) antibodies [18]. This evidence concerns the gene EGFR and colorectal cancer.